Clincosm LogoSign in Get a demo

Biological Aspects of Depression and Antidepressant Drugs

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00018733
Collaborator
(none)
1
Location
63
Duration (Months)

Study Details

Study Description

Brief Summary

This study will be measuring changes in depressive symptoms over a 7 week time period. Double-blind placebo controlled trial using the pharmacologic agents Paroxetine or Desipramine.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Allocation:
Randomized
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Biological Aspects of Depression and Antidepressant Drugs
Study Start Date :
Sep 1, 1996
Study Completion Date :
Dec 1, 2001

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 69 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    • Diagnosis of major depressive disorder Ham-D Score > 18

    • English speaking with ability to read and sign an informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 South Texas Veterans Health Care System San Antonio Texas United States 78229

    Sponsors and Collaborators

    • US Department of Veterans Affairs

    Investigators

    • : Steve Brannan, M.D.,
    • : Cheryl Gonzalez, M.D.,

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00018733
    Other Study ID Numbers:
    • MHBS-031-99F
    First Posted:
    Jul 5, 2001
    Last Update Posted:
    Jan 21, 2009
    Last Verified:
    Dec 1, 2004
    Keywords provided by , ,
    Depression
    Additional relevant MeSH terms:
    Depression
    Depressive Disorder
    Paroxetine
    Desipramine

    Study Results

    No Results Posted as of Jan 21, 2009